{"schema_version":"secwatch.filing_event.v1","accession":"0001615219-25-000045","form_type":"8-K","ticker":"DCOY","cik":"0001615219","company_name":"Decoy Therapeutics Inc.","filed_at":"2025-04-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.029100+00:00","generated_at":"2026-05-23T05:52:19.149307+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.9,"confidence":"high","headline":"Salarius Pharma receives Nasdaq delisting notice for bid price non-compliance; merger with Decoy planned","bullets":["Nasdaq notice on April 23, 2025 for failing minimum $1.00 bid price for 30 consecutive business days.","Ineligible for compliance period due to prior reverse stock split; also non-compliant with $2.5M equity standard.","Unless appeal by April 30, 2025, suspension and delisting scheduled for May 2, 2025; company intends to appeal.","Plans to present merger with Decoy Therapeutics Inc. to regain compliance at Nasdaq Hearings Panel."],"urls":{"canonical":"https://secwatch.observer/filing/0001615219-25-000045","json":"https://secwatch.observer/filing/0001615219-25-000045.json","markdown":"https://secwatch.observer/filing/0001615219-25-000045.md","text":"https://secwatch.observer/filing/0001615219-25-000045.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1615219/000161521925000045/0001615219-25-000045-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1615219/000161521925000045/flks-20250423.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T05:52:19.149307+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}